Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ)

Home
000623.SZ
Financials

16.09 (CNY) • At close October 26, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Revenue Numbers are in millions	3,449.123	2,868.211	2,303.764	2,251.651	3,088.38	3,324.078	2,976.772	2,736.697	2,334.761	2,240.099	1,956.861	1,445.463	1,145.231	1,113.328	1,025.515	927.822	845.147	770.229	767.322	820.775	673.734	573.816	359.634	314.183	423.009	368.058	330.446	242.69	173.134
Cost of Revenue Numbers are in millions	1,751.185	1,400.805	1,098.713	913.334	958.647	930.699	870.664	792.906	724.846	693.777	627.439	499.026	412.723	356.862	357.37	342.889	314.414	266.458	287.671	325.681	255.965	220.176	136.259	100.903	138.796	115.377	98.5	71.447	63.507
Gross Profit Numbers are in millions	1,697.938	1,467.406	1,205.051	1,338.317	2,129.733	2,393.379	2,106.108	1,943.791	1,609.914	1,546.323	1,329.423	946.437	732.508	756.465	668.145	584.933	530.733	503.771	479.65	495.094	417.769	353.64	223.375	213.281	284.213	252.681	231.946	171.243	109.627
Gross Profit Ratio Numbers are in millions	0.492	0.512	0.523	0.594	0.69	0.72	0.708	0.71	0.69	0.69	0.679	0.655	0.64	0.679	0.652	0.63	0.628	0.654	0.625	0.603	0.62	0.616	0.621	0.679	0.672	0.687	0.702	0.706	0.633
Reseach & Development Expenses Numbers are in millions	124.981	85.68	49.417	67.215	142.898	87.924	91.778	90.557	94.209	39.044	54.721	18.106	0	3.946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	160.523	125.017	123.148	184.757	212.661	194.118	173.47	151.354	174.346	152.317	120.781	84.585	74.302	59.199	162.007	145.045	126.831	124.365	118.978	120.525	100.065	82.826	44.074	34.446	50.059	27.714	19.146	23.337	8.55
Selling & Marketing Expenses Numbers are in millions	1,020.334	862.142	797.462	915.198	1,327.231	1,557.904	1,388.819	1,135.747	912.422	893.253	822.251	590.259	418.568	457.924	359.376	345.164	298.043	242.291	241.207	222.186	199.875	171.81	101.71	119.904	138.293	129.204	97.853	97.701	68.745
SG&A Numbers are in millions	1,180.856	987.158	920.61	1,099.954	1,539.892	1,752.022	1,562.288	1,287.101	1,086.768	1,045.57	943.032	674.843	492.87	517.124	521.383	490.21	424.874	366.655	360.184	342.711	299.94	254.636	145.784	154.349	188.352	156.918	116.999	121.038	77.296
Other Expenses Numbers are in millions	117.78	154.202	122.474	117.794	150.714	143.558	11.871	112.964	118.734	66.555	75.91	51.586	91.111	66.088	18.126	47.266	39.486	-9.475	13.723	43.933	54.426	21.703	14.574	4.522	17.448	31.603	-0.203	6.93	1.041
Operating Expenses Numbers are in millions	1,430.897	1,227.04	1,092.5	1,284.963	1,833.504	1,983.503	1,665.937	1,557.153	1,303.043	1,226.247	1,111.684	809.856	603.101	633.371	536.527	504.556	438.102	379.648	372.694	355.33	307.687	260.988	150.307	157.618	194.408	162.422	121.805	123.71	79.659
Operating Income Numbers are in millions	1,382.396	2,527.744	1,764.004	1,720.408	1,483.07	977.59	1,926.81	1,630.682	2,554.514	1,420.636	1,124.65	638.942	2,374.433	1,226.363	1,402.812	869.467	1,998.746	434.016	126.195	140.346	97.799	80.171	82.07	95.947	116.482	100.011	106.006	39.748	28.028
Operating Income Ratio Numbers are in millions	0.401	0.881	0.766	0.764	0.48	0.294	0.647	0.596	1.094	0.634	0.575	0.442	2.073	1.102	1.368	0.937	2.365	0.563	0.164	0.171	0.145	0.14	0.228	0.305	0.275	0.272	0.321	0.164	0.162
Total Other Income Expenses Net Numbers are in millions	117.78	-806.899	2.667	-3.853	-3.325	11.39	6.22	1,353.448	2,363.439	1,165.194	973.097	545.998	2,332.482	1,166.214	1,279.691	828.504	1,941.309	302.249	30.799	37.335	37.026	13.833	21.697	43.21	42.635	31.573	-5.558	-0.981	-1.162
Income Before Tax Numbers are in millions	1,500.176	1,720.845	1,766.67	1,716.555	1,479.745	988.98	1,933.03	1,740.086	2,670.311	1,485.269	1,190.836	682.579	2,461.888	1,289.308	1,411.309	908.881	2,033.94	425.457	138.837	180.689	149.667	104.18	95.705	99.671	133.185	126.723	105.192	46.615	28.937
Income Before Tax Ratio Numbers are in millions	0.435	0.6	0.767	0.762	0.479	0.298	0.649	0.636	1.144	0.663	0.609	0.472	2.15	1.158	1.376	0.98	2.407	0.552	0.181	0.22	0.222	0.182	0.266	0.317	0.315	0.344	0.318	0.192	0.167
Income Tax Expense Numbers are in millions	55.833	-80.002	-4.189	25.142	86.347	64.324	87.884	84.245	68.482	67.477	128.634	32.708	478.939	34.044	25.881	22.672	32.156	25.986	5.075	26.143	28.995	15.468	13.638	12.271	25.561	33.387	15.779	6.992	3
Net Income Numbers are in millions	1,459.88	1,780.801	1,780.5	1,708.876	1,403.64	935.188	1,863.471	1,666.491	2,593.589	1,410.693	1,058.789	646.417	1,982.049	1,237.656	1,366.489	861.608	1,992.26	387.923	110.523	116.849	99.101	75.562	76.168	82.616	100.323	89.819	89.413	39.622	25.937
Net Income Ratio Numbers are in millions	0.423	0.621	0.773	0.759	0.454	0.281	0.626	0.609	1.111	0.63	0.541	0.447	1.731	1.112	1.332	0.929	2.357	0.504	0.144	0.142	0.147	0.132	0.212	0.263	0.237	0.244	0.271	0.163	0.15
EPS Numbers are in millions	1.3	1.57	1.56	1.48	1.21	0.8	1.6	1.45	2.23	1.22	0.91	0.55	1.71	1.07	1.17	0.74	1.71	0.84	0.095	0.082	0.07	0.053	0.023	0.057	0.084	0.069	0.088	0.039	0.022
EPS Diluted Numbers are in millions	1.3	1.47	1.51	1.43	1.18	0.8	1.6	1.45	2.23	1.22	0.91	0.55	1.71	1.07	1.17	0.74	1.71	0.84	0.095	0.082	0.07	0.053	0.023	0.057	0.084	0.069	0.088	0.039	0.022
EBITDA Numbers are in millions	1,998.477	2,753.37	2,384.875	2,158.313	1,824.219	1,372.33	2,142.091	1,993.623	2,829.502	1,603.164	1,340.164	773.344	2,622.876	1,391.825	1,516.066	1,014.436	2,150.997	538.091	237.614	278.983	208.952	162.702	128.884	137.977	111.334	101.188	110.14	47.532	29.967
EBITDA Ratio Numbers are in millions	0.579	0.96	1.035	0.959	0.591	0.413	0.72	0.728	1.212	0.716	0.685	0.535	2.29	1.25	1.478	1.093	2.545	0.699	0.31	0.34	0.31	0.284	0.358	0.439	0.263	0.275	0.333	0.196	0.173

Jilin Aodong Pharmaceutical Group Co., Ltd.

SZSE:000623.SZ Add to watchlist

SZSE:000623.SZ